Skip to content
  • Home
  • About
  • Contact
  • Services
  • Advertise with Us
US Pharma Marketing Logo

US Pharma Marketing

  • Industry Landscape
  • Your POV
  • Sponsored
  • Case Studies & Trends
  • Job & Career
  • Strategy & Execution
  • Digital Transformation
  • Regulatory Compliance
  • Leader Q&A

Patient retention

How Pharma Companies Can Reduce Clinical Trial Dropouts
Posted in
  • Strategy & Execution

How Pharma Companies Can Reduce Clinical Trial Dropouts

Clinical trials represent one of the most complex and resource-intensive phases of pharmaceutical development. Before a … How Pharma Companies Can Reduce Clinical Trial DropoutsRead more

by Jayshree Gondane•March 5, 2026March 5, 2026•0
Why Pharma Companies Struggle With Trial Participant Retention
Posted in
  • Industry Landscape
  • Strategy & Execution

Why Pharma Companies Struggle With Trial Participant Retention

Nearly 30 percent of clinical trial participants withdraw before study completion in certain therapeutic areas, according … Why Pharma Companies Struggle With Trial Participant RetentionRead more

by Jayshree Gondane•February 15, 2026February 15, 2026•0

Recent Posts

  • How to Handle Price Objections in Pharma Sales
  • Remote Pharmaceutical Sales: Complete Guide
  • How to Navigate Group Purchasing Organizations (GPOs)
  • Selling Specialty Pharmaceuticals vs. Primary Care
  • How to Use Clinical Data in Sales Presentations

Recent Comments

No comments to show.
Copyright © 2026 US Pharma Marketing.
Powered by WordPress and HybridMag.
  • Industry Landscape
  • Your POV
  • Sponsored
  • Case Studies & Trends
  • Job & Career
  • Strategy & Execution
  • Digital Transformation
  • Regulatory Compliance
  • Leader Q&A